Skip to main navigation Skip to search Skip to main content

The P2X3 subunit: A molecular target in pain therapeutics

  • R. Alan North

Research output: Contribution to journal › Article › peer-review

Abstract

P2X receptors are hetero-oligomeric proteins that function as membrane ion channels and are gated by extracellular ATP. The P2X3 subunit is a constituent of the channels on a subset of sensory neurons involved in pain signaling, where ATP released by damaged and inflamed tissue can initiate action potentials. The tissue distribution of this subunit, along with experiments using antagonists, antisense oligonucleotides and gene knockouts, suggests that it may be a useful target for the development of pain therapeutics. This has been substantiated by the development by Abbott of a small molecule that selectively blocks P2X3 subunit-containing P2X receptors, and which is effective in a range of animal models of neuropathic and chronic inflammatory pain. © Current Drugs.
Original languageEnglish
Pages (from-to)833-840
Number of pages7
JournalCurrent Opinion in Investigational Drugs
Volume4
Issue number7
Publication statusPublished - 1 Jul 2003

Keywords

  • Antagonist
  • ATP
  • Chronic pain
  • Neuropathic pain
  • P2X receptors

Fingerprint

Dive into the research topics of 'The P2X3 subunit: A molecular target in pain therapeutics'. Together they form a unique fingerprint.

Cite this